Hinova Pharmaceuticals Inc. (SHA:688302)
China flag China · Delayed Price · Currency is CNY
32.91
-0.15 (-0.45%)
Sep 1, 2026, 4:00 PM EDT

Hinova Pharmaceuticals Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-131.62-137.25-199.5-294.16-301.51-306.18
Depreciation & Amortization
9.237.245.976.425.473.05
Other Amortization
0.050.050.040.040.040.63
Loss (Gain) From Sale of Assets
0.01-00.0100
Asset Writedown & Restructuring Costs
-3.61-----
Loss (Gain) From Sale of Investments
-13.39-15.35-13.11-24.83-28.89-23.56
Provision & Write-off of Bad Debts
-0.110----
Other Operating Activities
4.520.25-3.66-2.78-3.36.05
Change in Accounts Receivable
-2.751.355.925.764.043.96
Change in Inventory
-14.24-2.8400-0-0
Change in Accounts Payable
42.1628.99-7.54-21.85-93.6-20.6
Change in Other Net Operating Assets
1.928.6824.7975.88102.82108.82
Operating Cash Flow
-107.84-108.88-187.08-255.51-314.92-227.82
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-56.01-82.89-89.55-99.18-69.21-19.77
Sale of Property, Plant & Equipment
0000.020-
Investment in Securities
-150-10080-25-370-
Other Investing Activities
16.5443.18-20.724.8329.3123.2
Investing Cash Flow
-189.47-139.7-30.25-99.33-409.93.42

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---0.530-
Long-Term Debt Issued
-100----
Total Debt Issued
-100-0.530-
Short-Term Debt Repaid
----30.5--0.5
Long-Term Debt Repaid
--3.52-4.06-4.39-3.4-1.56
Total Debt Repaid
-1.67-3.52-4.06-34.89-3.4-2.06
Net Debt Issued (Repaid)
-1.6796.48-4.06-34.3926.6-2.06
Issuance of Common Stock
----1,010-
Common Dividends Paid
-2.54-1.24--0.9--2.56
Other Financing Activities
-2.04----19.31-3.86
Financing Cash Flow
-6.2695.24-4.06-35.291,017-8.48

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-5.44-2.291.431.757.8-1.99
Net Cash Flow
-309-155.64-219.96-388.38300.38-234.87

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-163.85-191.76-276.63-354.68-384.13-247.6
Free Cash Flow Growth
------
Free Cash Flow Margin
-263.12%-936.81%-75410.46%--23269.07%-
Free Cash Flow Per Share
-1.67-1.94-2.79-3.58-4.23-3.33
Levered Free Cash Flow
-162.61-203.51-159.1-230.86-252.88-145.13
Unlevered Free Cash Flow
-162.52-203.29-158.77-229.93-250.43-143.54

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
----3.92-
Cash Income Tax Paid
1.221.120.44-19.4-13.46-6.07
Change in Working Capital
27.0936.1923.1759.7913.2792.19